ID IDH_COREF Reviewed; 729 AA. AC Q8RQL9; DT 01-NOV-2002, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2002, sequence version 1. DT 25-NOV-2008, entry version 40. DE RecName: Full=Isocitrate dehydrogenase [NADP]; DE Short=IDH; DE EC=1.1.1.42; DE AltName: Full=Oxalosuccinate decarboxylase; GN Name=icd; OrderedLocusNames=CE0682; OS Corynebacterium efficiens. OC Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales; OC Corynebacterineae; Corynebacteriaceae; Corynebacterium. OX NCBI_TaxID=152794; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=DSM 44549 / YS-314 / AJ 12310 / JCM 11189 / NBRC 100395; RA Nonaka G., Kimura E., Kawahara Y., Sugimoto S.; RT "Corynebacterium efficiens icd gene for isocitrate dehydrogenase, RT complete cds."; RL Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=DSM 44549 / YS-314 / AJ 12310 / JCM 11189 / NBRC 100395; RX MEDLINE=22723752; PubMed=12840036; DOI=10.1101/gr.1285603; RA Nishio Y., Nakamura Y., Kawarabayasi Y., Usuda Y., Kimura E., RA Sugimoto S., Matsui K., Yamagishi A., Kikuchi H., Ikeo K., RA Gojobori T.; RT "Comparative complete genome sequence analysis of the amino acid RT replacements responsible for the thermostability of Corynebacterium RT efficiens."; RL Genome Res. 13:1572-1579(2003). CC -!- CATALYTIC ACTIVITY: Isocitrate + NADP(+) = 2-oxoglutarate + CO(2) CC + NADPH. CC -!- CATALYTIC ACTIVITY: Oxalosuccinate + NADP(+) = 2-oxoglutarate + CC CO(2) + NADPH. CC -!- COFACTOR: Binds 1 magnesium or manganese ion per subunit (By CC similarity). CC -!- ENZYME REGULATION: Weakly inhibited by oxaloacetate, 2- CC oxoglutarate, and citrate. Severely inhibited by oxaloacetate plus CC glyoxylate (By similarity). CC -!- SUBUNIT: Monomer (By similarity). CC -!- SIMILARITY: Belongs to the monomeric-type IDH family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AB083179; BAB88832.1; -; Genomic_DNA. DR EMBL; BA000035; BAC17492.1; ALT_INIT; Genomic_DNA. DR RefSeq; NP_737292.1; -. DR HSSP; P16100; 1ITW. DR SMR; Q8RQL9; 2-727. DR GeneID; 1033167; -. DR GenomeReviews; BA000035_GR; CE0682. DR KEGG; cef:CE0682; -. DR NMPDR; fig|196164.1.peg.682; -. DR HOGENOM; Q8RQL9; -. DR BioCyc; CEFF196164:CE0682-MON; -. DR GO; GO:0004450; F:isocitrate dehydrogenase (NADP+) activity; IEA:InterPro. DR GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-KW. DR GO; GO:0006097; P:glyoxylate cycle; IEA:UniProtKB-KW. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0006099; P:tricarboxylic acid cycle; IEA:InterPro. DR InterPro; IPR004436; IsoCit_DHase_NAD_mono. DR Pfam; PF03971; IDH; 1. DR PIRSF; PIRSF009407; IDH_monmr; 1. DR TIGRFAMs; TIGR00178; monomer_idh; 1. PE 3: Inferred from homology; KW Complete proteome; Glyoxylate bypass; Magnesium; Metal-binding; NADP; KW Oxidoreductase; Phosphoprotein; Tricarboxylic acid cycle. FT CHAIN 1 729 Isocitrate dehydrogenase [NADP]. FT /FTId=PRO_0000083594. FT NP_BIND 80 85 NADP (By similarity). FT NP_BIND 571 572 NADP (By similarity). FT NP_BIND 587 589 NADP (By similarity). FT REGION 121 128 Substrate binding (By similarity). FT METAL 337 337 Magnesium or manganese (By similarity). FT METAL 535 535 Magnesium or manganese (By similarity). FT BINDING 124 124 NADP (By similarity). FT BINDING 134 134 Substrate (By similarity). FT BINDING 534 534 Substrate (By similarity). FT BINDING 576 576 NADP (By similarity). FT BINDING 636 636 NADP (By similarity). FT SITE 244 244 Critical for catalysis (By similarity). FT SITE 407 407 Critical for catalysis (By similarity). SQ SEQUENCE 729 AA; 79285 MW; 84BCDECA8687627B CRC64; MAKIIWTRTD EAPLLATYSL KPVVEAFAAT AGIEVETRDI SLAGRILAQF ADQLPEEQKV SDALAELGEL AKTPEANIIK LPNISASVPQ LKAAVKELQE QGYDLPEYED AKDRYAAVIG SNVNPVLREG NSDRRAPVAV KNFVKKFPHR MGEWSADSKT NVATMGADDF RSNEKSVIMD EADTVVIKHV AADGTETVLK DSLPLLKGEV IDGTFISAKA LDAFLLDQVK RAKEEGILFS AHMKATMMKV SDPIIFGHIV RAYFADVYAQ YGEQLLAAGL NGENGLAAIY AGLDKLDNGA EIKAAFDKGL EEGPDLAMVN SAKGITNLHV PSDVIIDASM PAMIRTSGKM WNKDDQTQDA LAVIPDSSYA GVYQTVIEDC RKNGAFDPTT MGTVPNVGLM AQKAEEYGSH DKTFRIEADG KVQVVASNGD VLIEHDVEKG DIWRACQTKD APIQDWVKLA VNRARLSGMP AVFWLDPARA HDRNLTTLVE KYLADHDTEG LDIQILSPVE ATQHAIDRIR RGEDTISVTG NVLRDYNTDL FPILELGTSA KMLSVVPLMA GGGLFETGAG GSAPKHVQQV IEENHLRWDS LGEFLALAES FRHELNTRNN TKAGVLADAL DRATEKLLNE EKSPSRKVGE IDNRGSHFWL ATYWADELAN QTEDAELAET FAPVAEALNN QAADIDAALI GEQGKPVDLG GYYAPSDEKT SAIMRPVAAF NEIIDSLKK //